Market closed
McKesson/$MCK
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About McKesson
McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Ticker
$MCK
Sector
Trading on
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
48,000
Website
McKesson Metrics
BasicAdvanced
$79B
28.74
$21.82
0.52
$2.66
0.45%
Price and volume
Market cap
$79B
Beta
0.52
52-week high
$637.51
52-week low
$464.42
Average daily volume
793K
Dividend rate
$2.66
Financial strength
Current ratio
0.884
Quick ratio
0.46
Long term debt to equity
-219.822
Total debt to equity
-362.056
Dividend payout ratio (TTM)
11.89%
Interest coverage (TTM)
19.24%
Management effectiveness
Return on assets (TTM)
5.24%
Return on equity (TTM)
-137.03%
Valuation
Price to earnings (TTM)
28.736
Price to revenue (TTM)
0.234
Price to book
-25.62
Price to tangible book (TTM)
-5.41
Price to free cash flow (TTM)
49.449
Dividend yield (TTM)
0.42%
Forward dividend yield
0.45%
Growth
Revenue change (TTM)
14.29%
Earnings per share change (TTM)
-1.26%
3-year revenue growth (CAGR)
10.27%
3-year earnings per share growth (CAGR)
34.27%
3-year dividend per share growth (CAGR)
14.33%
What the Analysts think about McKesson
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for McKesson stock.
McKesson Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
McKesson Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
McKesson News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market closed
Upcoming events
Mar3
McKesson
Dividend·Ex-dividend
Apr1
McKesson
Dividend·Payment
$0.71
Per share
FAQs
What’s the current market cap for McKesson stock?
McKesson (MCK) has a market cap of $79B as of February 27, 2025.
What is the P/E ratio for McKesson stock?
The price to earnings (P/E) ratio for McKesson (MCK) stock is 28.74 as of February 27, 2025.
Does McKesson stock pay dividends?
Yes, the McKesson (MCK) stock pays dividends to shareholders. As of February 27, 2025, the dividend rate is $2.66 and the yield is 0.45%. McKesson has a payout ratio of 11.89% on a trailing twelve-month basis.
When is the next McKesson dividend payment date?
The next McKesson (MCK) dividend payment is scheduled for April 01, 2025.
What is the beta indicator for McKesson?
McKesson (MCK) has a beta rating of 0.52. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.